KRYSTAL BIOTECH INC (KRYS) Stock Analyst Ratings
USA - NASDAQ:KRYS - US5011471027 - Common Stock
186.13 USD
-0.32 (-0.17%)
186.13 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to KRYS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 209.93. This target is 12.79% above the current price.
KRYS was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KRYS.
In the previous month the buy percentage consensus was at a similar level.
KRYS was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-17 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-05 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-25 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-01 | Clear Street | Initiate | Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-05 | Jefferies | Initiate | Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-20 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | Citigroup | Maintains | Neutral -> Neutral |
KRYSTAL BIOTECH INC / KRYS FAQ
What do analysts expect the price target to be for KRYSTAL BIOTECH INC (KRYS)?
18 analysts have analysed KRYS and the average price target is 209.94 USD. This implies a price increase of 12.79% is expected in the next year compared to the current price of 186.13.
What is the consensus rating for KRYSTAL BIOTECH INC (KRYS) stock?
The consensus rating for KRYSTAL BIOTECH INC (KRYS) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed KRYSTAL BIOTECH INC (KRYS)?
The number of analysts covering KRYSTAL BIOTECH INC (KRYS) is 18.